Interruption of Miltenyi Biotec's order service

Posted date 20/11/2020

The German company Miltenyi Biotec, which provides clinical products and services, such as SARS-Cov-2 antigens for researchers, has reported that part of its global IT infrastructure was affected by malware, which resulted in the stoppage of order processing.

After detecting the incident, the company took appropriate measures to contain the malware and restore the affected systems.

So far, no customers or partners have been affected and all company operations have now been restored.

References